arformoterol tartrate
Drug ingredientThis chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
Where It Comes From
20 FDA-registered drug labelers
Alembic Pharmaceuticals Inc.
American Health Packaging
Aucta Pharmaceuticals, Inc.
Cipla Ltd.
Cipla USA Inc.
Devatis, Inc.
Dr. Reddy's Laboratories, Inc.
Fosun Pharma USA Inc.
Ingenus Pharmaceuticals, LLC
INKE, S.A.
Lifestar Pharma LLC
Lupin Pharmaceuticals, Inc.
Micro Labs Limited
MSN Laboratories Private Limited
NorthStar RxLLC
Ritedose Pharmaceuticals, LLC
Slate Run Pharmaceuticals
Sterling Pharma Solutions Limited
Sun Pharmaceutical Industries, Inc.
Teva Pharmaceuticals USA, Inc.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 3 drug and cosmetic product listings (FDA).
- •Arformoterol tartrate
- •Arformoterol Tartrate Inhalation Solution
- •Arformoterol Tartrate Inhalation
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS200815-49-2
PubChem CID9827062
DTXSIDDTXSID80173903
FormulaC23H30N2O10
Mol. Weight494.5 g/mol
SMILESCC(CC1=CC=C(C=C1)OC)NCC(C2=CC(=C(C=C2)O)NC=O)O.C(C(C(=O)O)O)(C(=O)O)O
Data Sources
98270622026-04-07
https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/arformoterol tartrate/cids/JSON
Archive: data/sources/pubchem_name/arformoterol tartrate.json
CAS 200815-49-22026-04-25
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json
bulk match2026-04-07
https://open.fda.gov/data/ndc/
Archive: data/sources/fda/ndc/ndc.json